Study suggests PD-1 inhibitors against aggressive pediatric brain cancer subtype One type of immunotherapy removes a genetic blindfold that cancer uses to hide from the immune system. These “PD-1 inhibitors,” including drugs like pembrolizumab, nivolumab and atezolizum...